Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0149514 (
bronchitis
)
6,902
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Surfactant protein D
(
SP-D
) is an important component of the pulmonary host defense system. We hypothesized that bronchoalveolar lavage (BAL)
SP-D
levels are lower in children presenting with recurrent
bronchitis
, providing evidence for a role of
SP-D
in human respiratory diseases.
SP-D
levels in BAL were measured in 45 children, who suffered from recurrent
bronchitis
for an average of 2-3 yr. Clinical outcome was assessed 2 yr after BAL. For comparison, BAL fluids from 15 control children without respiratory symptoms were evaluated. Among the 45 children with recurrent
bronchitis
, 12 had no
SP-D
in their BAL at the time of investigation. These
SP-D
-deficient patients had more frequently pneumonias and their long-term outcome was worse than that of the children with detectable
SP-D
. No genetic cause could be identified for the
SP-D
deficiency. Among the children with recurrent
bronchitis
and
SP-D
clearly detectable in BAL, those with the diagnosis of allergic asthma had threefold elevated levels compared with controls. In accordance with animal and in vitro data, elevated
SP-D
concentrations in BAL may represent an up-regulation due to allergic airway inflammation. In contrast,
SP-D
deficiency due to consumption or failure to up-regulate
SP-D
may be linked to pulmonary morbidity in children.
...
PMID:Children with absent surfactant protein D in bronchoalveolar lavage have more frequently pneumonia. 1826 31